SPONSOR
Nanfang Hospital, Southern Medical University
Total Trials
14
Recruiting
14
Phases
Phase 1, Phase 2, Phase 3, Phase 1, Phase 2, Phase 4
Conditions studied: CraniopharyngiomasLiver NeoplasmHBV InfectionNon-alcoholic Fatty Liver Disease NAFLDLiver FibrosisNon-small Cell Lung CancerNasopharyngeal CarcinomaHead and Neck CancerRadiotherapy-induced Oral MucositisBiomarker
Nanfang Hospital, Southern Medical University is a clinical research sponsor with 14 registered studies on ClinicalTrials.gov, of which 14 are actively recruiting participants. Research covers conditions including Craniopharyngiomas, Liver Neoplasm, HBV Infection, Non-alcoholic Fatty Liver Disease NAFLD.
The trial portfolio spans Phase 1, Phase 2, Phase 3, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Nanfang Hospital, Southern Medical University
How many clinical trials has Nanfang Hospital, Southern Medical University sponsored?
ClinicalMetric currently tracks 14 clinical trials sponsored by Nanfang Hospital, Southern Medical University, of which 14 are actively recruiting participants. These trials cover conditions including Craniopharyngiomas, Liver Neoplasm, HBV Infection. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Nanfang Hospital, Southern Medical University research focus on?
Nanfang Hospital, Southern Medical University clinical trials span Craniopharyngiomas, Liver Neoplasm, HBV Infection, Non-alcoholic Fatty Liver Disease NAFLD, Liver Fibrosis, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 3, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Nanfang Hospital, Southern Medical University clinical trial?
To participate in a Nanfang Hospital, Southern Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Nanfang Hospital, Southern Medical University trials with current recruitment status updated daily.
Clinical Trials by Nanfang Hospital, Southern Medical University
NCT06970145 Phase 1, Phase 2
Recruiting
Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma
Craniopharyngiomas
NCT07265544
Recruiting
Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
Liver Neoplasm
NCT06232265
Recruiting
An Observational Study on Predicting the Efficacy of Immunotherapy for NSCLC Based on LIRAscore
Non-small Cell Lung Cancer
NCT06307314
Recruiting
Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis
Nasopharyngeal Carcinoma
NCT07203352 Phase 3
Recruiting
Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL
Acute Lymphoblastic Leukemia
NCT05977283
Recruiting
HBsAg Declined Patients Follow-up Study
Hepatitis B
NCT06823895 Phase 1
Recruiting
Pharmacokinetic Study of Oligonucleotides in Maixuekang Capsules
Healthy
NCT06817239
Recruiting
Effect of Low-dose EsketaMine on dElirium in High-risk Elderly Patients uNdergoing elecTive Surgery (ELEMENT)
Delirium in Old Age
NCT06584565
Recruiting
A Multicenter Study Based on Multi-omics Analysis to Predict the Early Prognosis and Recurrence Risk of Acute Ischemic Stroke
Ischemic Stroke, Acute
NCT06708507
Recruiting
Tissue-resident Immune Cell Subsets in aGVHD
Acute Graft-versus-Host Disease
NCT06429696 Phase 2
Recruiting
PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer
Small Cell Lung Cancer Extensive Stage
NCT07622667
Recruiting
Correlation Analysis of Gene Characteristics of Malignant Tumors With Prognosis
Malignant Tumors
NCT06736860 Phase 4
Recruiting
Tranexamic Acid in Patients With Traumatic Bleeding Based on Dynamic Monitoring of Thromboelastography
Trauma Coagulopathy
NCT06988813
Recruiting
Bidirectional Cohort Study of Nanfang Spondyloarthritis
Spondyloarthritis (SpA)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology